Switch to:
More From Other Websites
Patients Seeking Alternatives to Statins May Undergo Rigorous Vetting Jul 27 2015
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bid Jul 27 2015
Teva to buy Allergan generic business for $40.5 bln, drops Mylan bid Jul 27 2015
Next biotech deal brewing? Jul 27 2015
Amgen Announces Webcast of 2015 Second Quarter Financial Results Jul 27 2015
Amgen Announces Webcast of 2015 Second Quarter Financial Results Jul 27 2015
Allergan to own 10% stake in Teva Jul 27 2015
4 Stocks Spiking on Unusual Volume Jul 27 2015
The Incredible Gilead Faces Its Moment of Truth Jul 27 2015
Why Regeneron's Approval is Bad News For Esperion Therapeutics Jul 27 2015
Biogen: Buy the Stock Get the Pipeline for Free Jul 27 2015
Teva to buy Allergan generic drug business for $40.5 bln Jul 27 2015
FDA Approves Kyprolis® (carfilzomib) For Combination Use In The Treatment Of Patients With Relapsed... Jul 27 2015
This Week’s Earnings Calendar Jul 26 2015
12:42 pm Amgen confirms FDA approval of Kyprolis (carfilzomib) for combination use in the treatment... Jul 26 2015
BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead Jul 26 2015
FDA OKs breakthrough cholesterol drug for high-risk patients Jul 24 2015
FDA OKs breakthrough cholesterol drug for high-risk patients Jul 24 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK